LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects.

Salva, Oscar / Alasino, Roxana / Giller, Celia / Borello, Julieta / Doresky, Alexis / Karayan, Galia / Beltramo, Dante

Platelets

2021  Volume 33, Issue 3, Page(s) 471–478

Abstract: We analyze changes in circulating platelets in COVID-19 positive patients who received conventional treatment Dexamethasone and Enoxaparin (Dexa-Enoxa) compared to patients treated with conventional therapy plus nebulization with alkaline hypertonic ... ...

Abstract We analyze changes in circulating platelets in COVID-19 positive patients who received conventional treatment Dexamethasone and Enoxaparin (Dexa-Enoxa) compared to patients treated with conventional therapy plus nebulization with alkaline hypertonic ibuprofenate (AHI). Results show that after 24 h of nebulization with AHI, circulating platelets shows an increase about 40% at 24 h and reach 65% at 96 h. In patients with platelets content below 200,000 by microliter the increase was 49% and 79% at 24 and 96 h respectively. In patients with platelets above 200,000 by microliter the increase was 24% and 31% at 24 and 96 h, respectively. The increase of platelets via AHI was similar in both, men and women.To evaluate whether this action of AHI was related to platelets from COVID-19 positive patients or also for healthy people, two controls were included: one of them with 10 healthy volunteers and another one with COVID-19 positive patients hospitalized and treated only with Dexa-Enoxa. Results show that, in healthy volunteers, the number of circulating platelets remains unchanged even after 7 days of treatment with AHI. In COVID-19 positive patients treated only with Dexa-Enoxa for 4 days, platelets increased only 16%.
MeSH term(s) Adult ; Blood Platelets/metabolism ; COVID-19/blood ; COVID-19/drug therapy ; Enoxaparin/administration & dosage ; Female ; Humans ; Ibuprofen/administration & dosage ; Male ; Middle Aged ; Nebulizers and Vaporizers ; Platelet Count ; SARS-CoV-2/metabolism
Chemical Substances Enoxaparin ; Ibuprofen (WK2XYI10QM)
Language English
Publishing date 2021-08-22
Publishing country England
Document type Clinical Trial ; Comparative Study ; Journal Article
ZDB-ID 1034283-7
ISSN 1369-1635 ; 0953-7104
ISSN (online) 1369-1635
ISSN 0953-7104
DOI 10.1080/09537104.2021.1967918
Shelf mark
Zs.A 2888: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top